Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bloomin’ Brands Inc (BLMN): Billionaire Steve Cohen Boosts Stake to 5.1%

In a new filing with the Securities and Exchange Commission, billionaire Steve Cohen‘s Point72 Asset Management disclosed boosting its position in Bloomin’ Brands Inc (NASDAQ:BLMN) to 6.37 million shares, which represent 5.1% of the company’s outstanding common stock. The stake was raised from 1.55 million shares that the fund reported in its latest 13F filing for the first quarter of 2015. During the first three months of the year, Point72 cut the position by around 707,700 shares.


The investor has been holding shares of Bloomin’ Brands Inc (NASDAQ:BLMN) for a while, disclosing ownership of 3.81 million shares in the first 13F for the second quarter of 2014. Moreover, Cohen’s previous fund, SAC Capital Advisors has also been a shareholder of Bloomin Brands until it was changed into Point72 Asset Management. Bloomin’ Brands Inc (NASDAQ:BLMN) is a $2.80 billion casual dining restaurant company, whose stock is down by 8.5% since the beginning of the year.

Bloomin’ Brands Inc (NASDAQ:BLMN) is relatively popular among the funds we track with 39 investors holding in aggregate around $664.81 million worth of stock as of the end of March. Moreover, the three largest shareholders among the funds from our database are billionaires Ken Griffin‘s Citadel Investment Group, Israel Englander’s Millennium Management and David E. Shaw’s D.E. Shaw, which own 4.19 million shares, 2.73 million shares and 2.56 million shares respectively. However, their stakes amass very small positions in their equity portfolios.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!